Does BREXPIPRAZOLE Cause Salivary hypersecretion? 31 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Salivary hypersecretion have been filed in association with BREXPIPRAZOLE (Rexulti). This represents 0.2% of all adverse event reports for BREXPIPRAZOLE.
31
Reports of Salivary hypersecretion with BREXPIPRAZOLE
0.2%
of all BREXPIPRAZOLE reports
2
Deaths
15
Hospitalizations
How Dangerous Is Salivary hypersecretion From BREXPIPRAZOLE?
Of the 31 reports, 2 (6.5%) resulted in death, 15 (48.4%) required hospitalization.
Is Salivary hypersecretion Listed in the Official Label?
Yes, Salivary hypersecretion is listed as a known adverse reaction in the official FDA drug label for BREXPIPRAZOLE.
What Other Side Effects Does BREXPIPRAZOLE Cause?
Weight increased (1,589)
Product use in unapproved indication (1,188)
Off label use (937)
Akathisia (807)
Drug ineffective (730)
Tardive dyskinesia (558)
Tremor (552)
Anxiety (475)
Product use issue (434)
Suicidal ideation (427)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which BREXPIPRAZOLE Alternatives Have Lower Salivary hypersecretion Risk?
BREXPIPRAZOLE vs BREXUCABTAGENE AUTOLEUCEL
BREXPIPRAZOLE vs BRIGATINIB
BREXPIPRAZOLE vs BRILINTA
BREXPIPRAZOLE vs BRILIQUE
BREXPIPRAZOLE vs BRIMONIDINE